Nebulizer Trial: Evaluation of the influence of particle size of aerosolized AMP on bronchial responsiveness in patients with asthma and the effects of treatment with ciclesonide vs fluticasone.
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Ciclesonide (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 31 Aug 2018 Biomarkers information updated
- 07 May 2012 Company (Takeda Global Research and Development Center) added to the associations field as reported by ClinicalTrials.gov record.
- 26 Oct 2009 New source identified and integrated ( Netherlands Clinical Trials Register record).